Clinical trial biostatistics and biopharmaceutical applications / edited by Walter R. Young, Ding-Geng (Din) Chen.
Contributor(s): Young, Walter R [editor.] | Chen, Ding-Geng [editor.].
Publisher: Boca Raton : CRC Press, 2015Description: xxxv, 544 pages ; 24 cm.Content type: text Media type: unmediated Carrier type: volumeISBN: 9781482212181 (hardback).Subject(s): Biostatistics -- methods | Clinical Trials as Topic | Research DesignGenre/Form: Print books.Summary: "Since 1945, "The Annual Deming Conference on Applied Statistics" has been an important event in the statistics profession. In Clinical Trial Biostatistics and Biopharmaceutical Applications, prominent speakers from past Deming conferences present novel biostatistical methodologies in clinical trials as well as up-to-date biostatistical applications from the pharmaceutical industry. Divided into five sections, the book begins with emerging issues in clinical trial design and analysis, including the roles of modeling and simulation, the pros and cons of randomization procedures, the design of Phase II dose-ranging trials, thorough QT/QTc clinical trials, and assay sensitivity and the constancy assumption in noninferiority trials. The second section examines adaptive designs in drug development, discusses the consequences of group-sequential and adaptive designs, and illustrates group sequential design in R. The third section focuses on oncology clinical trials, covering competing risks, escalation with overdose control (EWOC) dose finding, and interval-censored time-to-event data. In the fourth section, the book describes multiple test problems with applications to adaptive designs, graphical approaches to multiple testing, the estimation of simultaneous confidence intervals for multiple comparisons, and weighted parametric multiple testing methods. The final section discusses the statistical analysis of biomarkers from omics technologies, biomarker strategies applicable to clinical development, and the statistical evaluation of surrogate endpoints.This book clarifies important issues when designing and analyzing clinical trials, including several misunderstood and unresolved challenges. It will help readers choose the right method for their biostatistical application. Each chapter is self-contained with references"--Provided by publisher.Current location | Call number | Status | Date due | Barcode | Item holds |
---|---|---|---|---|---|
On Shelf | R853.S7 C57 2015 (Browse shelf) | Available | AU0000000008796 |
Browsing Alfaisal University Shelves , Shelving location: On Shelf Close shelf browser
R853.S7 A325 2015 Sample size calculations for clustered and longitudinal outcomes in clinical research / | R853.S7 C36 2021 Medical statistics : a textbook for the health sciences / | R853.S7 C464 2016 Biostatistics for epidemiology and public health using R / | R853.S7 C57 2015 Clinical trial biostatistics and biopharmaceutical applications / | R853.S7 D39 2008 Easy interpretation of biostatistics : the vital link to applying evidence in medical decisions / | R853.S7 E27 2016 Essentials of a successful biostatistical collaboration / | R853.S7 G54 2016 Understanding statistical error : a primer for biologists / |
Includes bibliographical references and index.
"Since 1945, "The Annual Deming Conference on Applied Statistics" has been an important event in the statistics profession. In Clinical Trial Biostatistics and Biopharmaceutical Applications, prominent speakers from past Deming conferences present novel biostatistical methodologies in clinical trials as well as up-to-date biostatistical applications from the pharmaceutical industry. Divided into five sections, the book begins with emerging issues in clinical trial design and analysis, including the roles of modeling and simulation, the pros and cons of randomization procedures, the design of Phase II dose-ranging trials, thorough QT/QTc clinical trials, and assay sensitivity and the constancy assumption in noninferiority trials. The second section examines adaptive designs in drug development, discusses the consequences of group-sequential and adaptive designs, and illustrates group sequential design in R. The third section focuses on oncology clinical trials, covering competing risks, escalation with overdose control (EWOC) dose finding, and interval-censored time-to-event data. In the fourth section, the book describes multiple test problems with applications to adaptive designs, graphical approaches to multiple testing, the estimation of simultaneous confidence intervals for multiple comparisons, and weighted parametric multiple testing methods. The final section discusses the statistical analysis of biomarkers from omics technologies, biomarker strategies applicable to clinical development, and the statistical evaluation of surrogate endpoints.This book clarifies important issues when designing and analyzing clinical trials, including several misunderstood and unresolved challenges. It will help readers choose the right method for their biostatistical application. Each chapter is self-contained with references"--Provided by publisher.